Med Fusion has entered into a market development agreement to validate the clinical utility of Theranostics Health's TheraLink assays for use in patients with malignant diseases. TheraLink assays are designed to measure the activation ...
Tags: TheraLink assays, clinical services, clinical trials, diagnostic